More detailed investigation of the role of the Nrf2 pathway and cross-talk with other signaling systems, such as the PI3K-Akt pathway, may eventually lead to new treatments for UTUC. Here, NFE2L2 is linked to renal pelvis/ureter urothelial carcinoma.